USPSTF Urges Screening Young Women for Chlamydia, Gonorrhea
All sexually active women aged 24 years and younger should be screened as well as women older than 25 at high risk
Response to One Dose of COVID-19 Vaccine Strong for Previously Infected
Two studies show higher anti-S titers in those with previous infection and very strong T-cell responses
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Preliminary Data in Israel Show COVID-19 Vaccines Effectively Prevent Severe Disease
National study shows reduction in ratio of COVID-19 patients requiring mechanical ventilation aged 70 years and older to those younger than 50 years
One-Third of U.S. Adults Continue to Be Hesitant About COVID-19 Vaccines
Rates of vaccine hesitancy particularly high among Black adults and Republicans, a December survey reveals
Dramatic Decline Seen in COVID-19 Cases, Deaths at U.S. Nursing Homes
82 percent decline reported in new COVID-19 cases among residents at nursing homes since the peak during the week of Dec. 20
J&J COVID-19 Vaccine Granted Emergency Use Authorization
The single-dose Ad26 vaccine is now the third COVID-19 vaccine to be granted an EUA
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine
COVID-19 Outcomes No Worse for People With Asthma
Patients with asthma may have a lower risk for becoming infected
AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants
Oxford team working on modifying vaccine to fight new variants, expects new version to be available in the fall
